| Date Filed | Type | Description |
| 11/03/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/12/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/11/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/03/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 12/09/2020 |
SC 13G/A
| ACT Capital Management, LLLP reports a 1.3% stake in HyreCar, Inc. |
| 02/07/2020 |
SC 13G/A
| ACT Capital Management, LLLP reports a 5.2% stake in HyreCar, Inc. |
| 02/07/2020 |
SC 13G/A
| ACT Capital Management, LLLP reports a 5.6% stake in Soligenix, Inc. |
| 02/07/2020 |
SC 13G/A
| ACT Capital Management, LLLP reports a 5.2% stake in HyreCar, Inc. |
| 04/18/2019 |
SC 13G/A
| ACT Capital Management, LLLP reports a 3.8% stake in Edison Nation Inc. |
| 02/14/2019 |
SC 13G/A
| ACT Capital Management, LLLP reports a 5.9% stake in Edison Nation Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/04/2019 |
SC 13G
| ACT Capital Management, LLLP reports a 8% stake in HyreCar, Inc. |
| 12/26/2018 |
SC 13G/A
| ACT Capital Management, LLLP reports a 4.3% stake in Hancock Jaffe Laboratories, Inc. |
| 08/10/2018 |
SC 13G/A
| ACT Capital Management, LLLP reports a 1.4% stake in Ampio Pharmaceuticals, Inc. |
| 07/30/2018 |
SC 13G/A
| ACT Capital Management, LLLP reports a 8.4% stake in Soligenix, Inc. |
| 06/15/2018 |
SC 13G
| ACT Capital Management, LLLP reports a 6.4% stake in Hancock Jaffe Laboratories, Inc. |
| 05/09/2018 |
SC 13G
| ACT Capital Management, LLLP reports a 9.3% stake in Xspand Product Labs, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/07/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/27/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/16/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/06/2017 |
SC 13G/A
| MOBIVITY HOLDINGS CORP. reports a 4.8% stake in Mobivity Holdings Inc. |
| 07/22/2016 |
SC 13G/A
| ACT Capital Management, LLLP reports a 4.4% stake in Ampio Pharmaceuticals, Inc. |
| 02/08/2016 |
SC 13G/A
| COMMERCETEL CORP reports a 6.1% stake in Mobivity Holdings Inc. |
| 08/01/2013 |
SC 13G
| COMMERCETEL CORP reports a 10% stake in Mobivity Holdings Inc. |
| 05/08/2013 |
SC 13G/A
| ACT Capital Management, LLLP reports a 6.4% stake in Ampio Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/09/2012 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 01/31/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 12/14/2011 |
SC 13G/A
| ACT Capital Management, LLLP reports a 6.7% stake in GigOptix, Inc. |
|